⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

SEER

Seer, Inc.

Healthcare · Biotechnology

1.97USD

+0.0000 (+0.00%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on SEER.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 1.97
P/E—
Dvd Ind Yld0.0%
P/B0.48
P/S7.7
Curr EV/T12M EBITDA0.3
Mkt Cap (USD)0.1B
Curr EV (USD)-0.0B
2)

Per Share Data

EPS T12M-1.30
DPS—
Bk Val Per Sh4.08
Rev/Sh0.23
Cash/Sh2.76
Curr Shares Out55.4M
FCF/Sh-0.72
3)

Cash Flow Analysis

P/CF-2.5
Curr P/FCF-2.5
CF/NI0.6
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-305.1%
Eff Interest Rate0.0%
4)

Growth Potential

Dil EPS 1Y Gr9.4%
Cap 1Y Gr-20.8%
BPS 1Y Gr-13.2%
R&D To Sales264.1%
Retention Rate—
Rev 1Y Gr17.0%
FCF 1Y Gr6.9%
Assets 1Y Gr-19.2%
5)

Profitability

EBITDA-0.1B
EBIT-0.1B
Operating Margin-498.2%
Pretax Margin-477.5%
Net Margin-478.0%
ROA-23.5%
ROE-26.4%
ROC—
Asset Turnover0.05
6)

Structure

Current Ratio14.74
Quick Ratio13.87
Debt/Assets8.7%
Debt/Com Eq9.9%
Net Debt/EBITDA0.06
Tot Debt/Capital9.0%
Gross Margin47.7%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.